AbbVie shareholders re-elect all Class II directors; reject supermajority elimination and independent chair proposal

AbbVie Inc.

All four Class II directors elected: Davis (1.22B for), Meyer (1.28B), Michael (1.22B), Waddell (1.23B).
Ratification of EY as auditor approved with 1.52B votes for, 23.8M against.
Advisory say-on-pay approved with 1.23B for, 69.3M against.
Proposal to eliminate supermajority voting did not pass: 1.29B for (needed supermajority).
Stockholder proposal for independent chair rejected: 515.6M for, 787.3M against.

item 5.07

Source: SEC EDGAR

accession 0001104659-26-059484

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.